Procter & Gamble is a global consumer goods company that serves consumers in approximately 65 countries with a portfolio of trusted brands across five business segments: Beauty (including Hair Care, Personal Care, and Skin Care), Grooming, Health Care (including Oral Care and Personal Health Care), Fabric & Home Care (including Fabric Care and Home Care), and Baby, Feminine & Family Care (including Baby Care, Feminine Care, and Family Care). The company's brand portfolio includes Tide, Pampers, Gillette, Crest, Oral-B, Olay, Pantene, Head & Shoulders, SK-II, Dawn, Downy, Bounty, Charmin, Always, Febreze, Gain, Ariel, Vicks, and Whisper, among others. P&G focuses on delivering superior products through innovation-based pricing and premium product mix strategies while pursuing ongoing productivity improvements. The company recently acquired Thorne, expanding its health and wellness portfolio, and is executing a portfolio and productivity restructuring plan announced in June 2025 expected to incur approximately $2 billion in before-tax costs over two years. Updated
P&G's fresh high at $173.14 tops the prior peak set just three sessions earlier, capping a steep autumn climb in a stock income investors treat as defensive ballast. The move follows a board appointment disclosed by Walmart, a customer, on Monday.
Mad Money: Wall Street Jargon, Cyclicals, GARP & Corrections 11/13/26
Cramer defines cyclicals as economy-dependent: miners like BHP, autos, homebuilders, commodity chemicals
Secular growers are the recession-proof side: Procter & Gamble, General Mills, Pfizer, Merck, Eli Lilly
He flags GLP-1 drugs as the one threat to the eat-and-drink-forever staples thesis
Caller advice: 70% stocks even for older investors, and ease idle IRA cash in one-twelfth a month
The practical call is positioning: own more cyclicals when business is booming and lean on staples and drugmakers when growth rolls over. Cramer says sector membership now drives well over half of a stock's move thanks to sector ETFs, so being in the wrong camp costs you even when the company executes.
Cramer says Nvidia leadership turmoil has made him gun shy on tech, yet writing off data center names risks big upside
CoreWeave CEO: compute demand 10 times oversubscribed for 2027, with chips recontracting at 20% to 50% premiums
Cramer would rather own Colgate or Johnson & Johnson than chase the noise right now
Caller questions on Darden's Olive Garden value proposition, Meta re-entry, and Jersey Mike's under Charlie Morrison
The tell is that four-year-old GPUs are being recontracted above their original prices, which undercuts the view that AI hardware depreciates into worthlessness. Cramer is keeping data center exposure in semis, networking, turbines and cooling even while trimming elsewhere, and he is leaning defensive with staples and pharma as the Nvidia story gets messier.
Oil's drop pulled long rates down, lifting Amazon, Capital One, JP Morgan, Costco and Walmart on no company news
Non-tech growth is where the money went: medical devices like Medtronic and Intuitive Surgical, plus staples Pepsi and P&G
Apple's record September quarter beat on iPhone and Mac, but Cramer expects the stock lower short term on guidance
Oracle filed to raise $20 billion days after saying it would limit raises; Intel seen losing PC share to AMD
The call is that falling long rates are repricing everything outside tech right now rather than earnings, and Cramer says growth stocks away from semis are the clean way to play it. He is warning Apple holders that guidance will disappoint even after a record quarter, and he is openly annoyed at Oracle for raising capital immediately after promising restraint.
Sold PROCTER & GAMBLE Co$5.7M35,000 shares @ $163.087
P&G's CEO exercised options at $78.52 and immediately sold all 35,000 shares at $163.09, pocketing roughly $5.7 million and cutting his direct stake by about 39%. Same-day exercise-and-sell is routine compensation mechanics, but it leaves no new skin in the game at these levels.
New 52-week high$165.59+0.5% vs prior high · 2026-02-27
A fiscal Q1 earnings beat pushed P&G to $165.59, a fresh 52-week high that clears its February 27 peak by 0.5%. The staples giant spent eight months going nowhere before this week.
Spotify opened up 10.5% to lead a 389-name board, with Lockheed Martin close behind at 9.3%. The pain is concentrated in chip gear and optics, where Lam Research gave up 10.2% at the bell.
Core EPS guidance stays at $6.89 to $7.11 despite a strong start, because roughly $1.4 billion in after-tax commodity costs lands this year. All five segments grew organically to open fiscal 2027, a breadth of demand P&G has not shown in a while, and both lines topped consensus.
Diversification pitch: Korean memory selling in SK Hynix and Samsung is bleeding into US data center names
Schwab called a buy near $94, under 15x this year's earnings, after AI displacement fears knocked it from $114
Chevron preferred over Exxon on a swap; Home Depot held as the most rate-levered name he knows
Trim half of Oracle after the run; Microsoft left alone into earnings on Azure strength
Cramer is pulling money toward consumer staples, retailers and oils while the data center complex cracks, and he is framing Schwab's selloff on AI-agent worries as a repeat of the 2023 banking scare that proved a buying opportunity. For anyone concentrated in AI hardware, the Oracle half-sell is the clearest sell discipline he offered all episode.
More than 600 ETFs now bet on a single stock, and one market veteran says the people buying them are losing badly while the sponsors cash in. Why does a simple 10%…
The Schwab U.S. Dividend Equity ETF (NYSEARCA:SCHD) grounds countless retirement portfolios. SCHD screens for durable dividend payers, holds $112.3 billion in net assets and pays a trailing yield near 2.94%. Retirees hold…
Cancer drugs, detergent, and soda have funded more than 50 straight years of dividend hikes. But a talc settlement, a pending IRS ruling, and rising commodity costs test whether each payout can…
Retirees who live on dividends need payouts that keep arriving and keep rising through recessions, rate changes and weak quarters. Four healthcare and consumer staples companies meet that standard. They have long,…
Market indicators are flashing red heading into October, and investors who wait too long to reposition may regret it. Five elite dividend stocks in healthcare, consumer staples, and utilities have weathered every…
A strong October quarter sent P&G shares climbing toward a 52-week high, yet oil prices and shrinking margins threaten the rally. Can volume-led growth and a looming Investor Day outrun the commodity…
Real yields hit a level that crushed income stocks once before, and one dividend name is already repeating the old script. Which holdings sat out the damage this time, and what single…
Retirement income works best when the checks keep arriving through recessions, wars, inflation scares, and market crashes. Three American companies have been doing exactly that for well over a century. Coca-Cola (NYSE:…
Two Dividend Kings, one decade, and a gap that mostly opened in the last five years. A streak of annual raises tells only part of the story, and the stock that stalled…
When Congress locks up, some dividends barely notice. Four blue chips span power, soap, medicine and banking, and one of them already survived a payout collapse that income investors should not forget…
Some brands simply outlast every fad. A Coke at the ballpark, a jug of Tide in the laundry room and a box of Kleenex on the nightstand have been fixtures in American…
The price chart you check for Procter & Gamble hides a big part of the story. One brokerage setting, a financial crisis nobody planned, and a stock that trails the S&P 500…
A guaranteed bank rate sounds safe until you weigh what it can't do. Six blue-chip payers offer income that can grow, but a board can cut it at any meeting, and the…
When profits dip, lenders get paid first and the dividend is usually what gets cut. Four household names have raised their payouts year after year, and one of them holds a credit…
Tech is bleeding while soda and detergent makers rally, and Jim Cramer wants to camp out in staples "for a bit." Two dividend legends have very different runs behind them, and only…
Procter & Gamble is a global consumer goods company that serves consumers in approximately 65 countries with a portfolio of trusted brands across five business segments: Beauty (including Hair Care, Personal Care, and Skin Care), Grooming, Health Care (including Oral Care and Personal Health Care), Fabric & Home Care…
What is the PG stock price target?
24/7 Wall St.'s 12-month price target for PG is $188.01, rated Buy. The Wall Street consensus target is $174.04. PG price prediction →